ArticleArchives of osteoporosis2026

Romosozumab for cancer treatment-induced bone loss in postmenopausal women with hormone receptor-positive breast cancer: a case series.

Shohei Tsujino et al.PubMed ↗Publisher ↗

No numbers read from the abstract.